Health

Johnson & Johnson Innovation – JJDC, Koch Strategic Platforms and Dentsu Ventures are all shareholders in the diagnostic testing technology developer.

The blood disease specialist secured a boost from Alexandria Real Estate Equities, Novo and Access Biotechnology to move two assets into phase 2 trials.

Alexandria Venture Investments is among the investors supporting the immunotherapy developer focused on cancer, autoimmune and infectious diseases.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Penn Medicine and Wharton Social Impact Initiative have launched an investment fund focused on the drivers of health equity.

Ventura Capital has led the round for the Imperial College London-founded rapid covid-19 test kit maker, which will use the funding to expand internationally.

Penn Medicine and Wharton Social Impact Initiative have launched an investment fund focused on the drivers of health equity.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Ally had raised $10m in seed funding from investors including UCB but disappointing animal studies led the company to be wound down.

The Harvard spinout had raised $10m in seed funding from investors including Arch Venture Partners, but disappointing animal studies led the company to be wound down.

The sleep improvement-themed firm’s first fund counts ResMed as an investor, while the latter’s SleepScore Labs subsidiary helps its portfolio companies with product development.